Esophagectomy and hepatic arterial chemotherapy following hepatic resection for esophageal cancer with liver metastasis

We report a patient who had simultaneous transthoracic esophagectomy and he patic arterial cannulation for chemotherapy following hepatic resection for esophageal cancer with solitary liver metastasis. He had an uneventful pos toperative course and received two cycles of postoperative arterial chemoth erapy with cisplatinum and 5-fluorouracil. He developed multiple liver meta stases 6 months after the surgery. He has been receiving arterial chemother apy at the outpatient department and is alive 15 months after the surgery. Aggressive esophagectomy and hepatic arterial chemotherapy is the treatment of choice for esophageal cancer with liver metastasis when unresectable me tastases are confined to the liver.